P. Arikoski et al., Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: A 1-year prospective study, J CLIN END, 84(9), 1999, pp. 3174-3181
In the present study, longitudinal changes in bone mineral density, bone tu
rnover, and bone hormonal metabolism were evaluated in newly diagnosed chil
dren with cancer. Lumbar spine (L2-L4) and femoral neck bone mineral densit
ies(grams per cm(2)) were measured by dual energy x-ray absorptiometry in 2
8 children (age, 2.9-16.0 yr; median, 8.0 yr; 10 acute lymphoblastic leukem
ias, 18 solid tumors) at diagnosis and after a l-yr follow-up. Apparent vol
umetsic density (grams per cm(3)) was calculated to minimize the effect of
bone size on BMD. Serum levels of osteocalcin (OC), type I collagen carboxy
l-terminal propeptide (PICP), and type I collagen carboxyl-terminal telopep
tide were measured serially during the study. Serum 25-hydroxyvitamin D, 1,
25-dihydroxyvitamin D, insulin-like growth factor I(IGF-I), and IGF-binding
protein-3 were analyzed at diagnosis and at l-yr follow-up.
A significant decrease in femoral bone mineral density and apparent volumet
ric density was observed during the year after diagnosis [(mean(SD), -10.1%
(8.8%) and -11.3%(8.1%) respectively; P<0.01], whereas age- and sex-matched
controls showed annual increments of +5.4% (7.7%; P<0.01) and +0.7% (5.7%;
P = NS) respectively. The markers of bone formation (PICP and OC) were sig
nificantly decreased at diagnosis. By the end of the follow-up, PICP and OC
were normalized, whereas the marker of bone resorption (type I collagen ca
rboxyl-terminal telopeptide) was significantly increased. Reduced levels of
25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and IGF-binding protein-3 we
re observed during the study.
To conclude, increased bone resorption and impaired development of femoral
bone density were observed in children with cancer during chemotherapy. Def
icient accumulation of bone mass may lead to impaired development of peak b
one mass and predispose children with cancer to increased risk of osteoporo
sis and diminished skeletal resistance to fractures later in Life.